GlassScriptPhysician profile
Raza Mian
NPI 1518373869
$13,309.85
in general payments reported to CMS, 2019-2025
12 companies · $18.70 in 2025
The $18.70 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $110 · 2021: $264 · 2022: $11K · 2023: $1,046 · 2024: $72.77 · 2025: $18.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698 · Travel and Lodging: $275 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.95 |
| Travel and Lodging | $274.50 |
| Education | $165.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,013.15 | 2022-2023 | Dragonfly Opstar |
| Medtronic, INC. | $4,406.49 | 2022-2023 | Onyx Frontier |
| Boston Scientific Corporation | $2,583.90 | 2019-2022 | |
| Edwards Lifesciences Corporation | $546.45 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $456.24 | 2019-2024 | Lifevest |
| Pfizer INC. | $99.16 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $82.99 | 2019 | |
| Baxter Healthcare | $33.57 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $31.13 | 2021-2025 | Repatha |
| Shockwave Medical, INC | $26.73 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Lexicon Pharmaceuticals, INC. | $15.34 | 2023 | Inpefa |
| Abiomed | $14.70 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raza Mian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.